Aylin Yilmaz

2.6k total citations
68 papers, 1.8k citations indexed

About

Aylin Yilmaz is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Aylin Yilmaz has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 44 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Aylin Yilmaz's work include HIV Research and Treatment (44 papers), HIV/AIDS Research and Interventions (36 papers) and HIV/AIDS drug development and treatment (17 papers). Aylin Yilmaz is often cited by papers focused on HIV Research and Treatment (44 papers), HIV/AIDS Research and Interventions (36 papers) and HIV/AIDS drug development and treatment (17 papers). Aylin Yilmaz collaborates with scholars based in Sweden, United Kingdom and United States. Aylin Yilmaz's co-authors include Magnus Gisslén, Richard W. Price, Lars Hagberg, Staffan Nilsson, Henrik Zetterberg, Dietmar Fuchs, Kaj Blennow, Serena Spudich, Lars‐Magnus Andersson and Magnus Lindh and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Aylin Yilmaz

61 papers receiving 1.8k citations

Peers

Aylin Yilmaz
Tracy Fischer United States
Shibani S. Mukerji United States
Kunling Wu United States
Helena Bacellar United States
Ned Sacktor United States
Sarah E. Beck United States
Katrin Hahn Germany
Deshratn Asthana United States
Aylin Yilmaz
Citations per year, relative to Aylin Yilmaz Aylin Yilmaz (= 1×) peers Catherine L. Cherry

Countries citing papers authored by Aylin Yilmaz

Since Specialization
Citations

This map shows the geographic impact of Aylin Yilmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aylin Yilmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aylin Yilmaz more than expected).

Fields of papers citing papers by Aylin Yilmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aylin Yilmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aylin Yilmaz. The network helps show where Aylin Yilmaz may publish in the future.

Co-authorship network of co-authors of Aylin Yilmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Aylin Yilmaz. A scholar is included among the top collaborators of Aylin Yilmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aylin Yilmaz. Aylin Yilmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Navér, Lars, Jan Albert, Christina Carlander, et al.. (2024). Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024. Infectious Diseases. 56(8). 657–668.
3.
Hagberg, Lars, Jan Lycke, Henrik Zetterberg, et al.. (2024). IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis. Clinical Chemistry and Laboratory Medicine (CCLM). 62(10). 2024–2029. 4 indexed citations
4.
Hu, Zicheng, Paola Cinque, Ameet Dravid, et al.. (2024). Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection. PLoS Pathogens. 20(9). e1012470–e1012470.
5.
Edén, Arvid, Aylin Yilmaz, Lars Hagberg, et al.. (2023). Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection. Open Forum Infectious Diseases. 10(2). ofad064–ofad064. 3 indexed citations
8.
Marklund, Emelie, Susannah Leach, Kristina Nystrôm, et al.. (2021). Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses. Frontiers in Immunology. 12. 750448–750448. 9 indexed citations
9.
Zetterberg, Henrik, Staffan Nilsson, Bruce J. Brew, et al.. (2021). Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection. BMC Neurology. 21(1). 494–494. 11 indexed citations
10.
Studahl, Marie, et al.. (2020). Increased risk of hepatotoxicity and temporary drug withdrawal during treatment of active tuberculosis in pregnant women. International Journal of Infectious Diseases. 98. 138–143. 4 indexed citations
11.
Yilmaz, Aylin, Dietmar Fuchs, Richard W. Price, et al.. (2019). Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. Current HIV/AIDS Reports. 16(1). 76–81. 9 indexed citations
12.
Yilmaz, Aylin, Markus Axelsson, Kaj Blennow, et al.. (2019). Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection. Journal of Neuroinflammation. 16(1). 16–16. 26 indexed citations
13.
Carlander, Christina, Leo Flamholc, Bo Hejdeman, et al.. (2018). Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations. International Journal of Antimicrobial Agents. 51(5). 733–738. 19 indexed citations
14.
Elvstam, Olof, Patrik Medstrand, Aylin Yilmaz, et al.. (2017). Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment. PLoS ONE. 12(7). e0180761–e0180761. 50 indexed citations
15.
Kaya, Ertuğrul, Aylin Yilmaz, Ayhan Sarıtaş, et al.. (2015). Acute intoxication cases admitted to the emergency department of a university hospital. World Journal of Emergency Medicine. 6(1). 54–54. 12 indexed citations
16.
Yilmaz, Aylin, Karin Jennbacken, & Linda Fogelstrand. (2014). Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection. BMC Infectious Diseases. 14(1). 143–143. 5 indexed citations
17.
Yilmaz, Aylin, Chris Verhofstede, Antonio D’Avolio, et al.. (2010). Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(5). 590–596. 52 indexed citations
18.
Yilmaz, Aylin, Magnus Gisslén, Serena Spudich, et al.. (2009). Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection. PLoS ONE. 4(9). e6877–e6877. 66 indexed citations
19.
Yilmaz, Aylin, Victoria Watson, Laura Else, & Magnus Gisslén. (2009). Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients. AIDS. 23(18). 2537–2540. 50 indexed citations
20.
Yilmaz, Aylin, Richard W. Price, Serena Spudich, et al.. (2008). Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2). 168–173. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026